Cargando…

Efficacy and tolerability of bevacizumab in patients with severe Covid-19

On the basis of Covid-19-induced pulmonary pathological and vascular changes, we hypothesize that the anti-vascular endothelial growth factor (VEGF) drug bevacizumab might be beneficial for treating Covid-19 patients. From Feb 15 to April 5, 2020, we conducted a single-arm trial (NCT04275414) and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Jiaojiao, Xu, Feng, Aondio, Gianmarco, Li, Yu, Fumagalli, Alberto, Lu, Ming, Valmadre, Giuseppe, Wei, Jie, Bian, Yuan, Canesi, Margherita, Damiani, Giovanni, Zhang, Yuan, Yu, Dexin, Chen, Jun, Ji, Xiang, Sui, Wenhai, Wang, Bailu, Wu, Shuo, Kovacs, Attila, Revera, Miriam, Wang, Hao, Jing, Xu, Zhang, Ying, Chen, Yuguo, Cao, Yihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864918/ https://www.ncbi.nlm.nih.gov/pubmed/33547300 http://dx.doi.org/10.1038/s41467-021-21085-8

Ejemplares similares

Adenosine Kinase Inhibition Prevents Severe Acute Pancreatitis via Suppressing Inflammation and Acinar Cell Necroptosis
por: Sun, Shukun, et al.
Publicado: (2022)

Poly (ADP‐ribose) polymerase inhibition protects against myocardial ischaemia/reperfusion injury via suppressing mitophagy
por: Cao, Shengchuan, et al.
Publicado: (2019)

Fundamental Mechanisms of the Cell Death Caused by Nitrosative Stress
por: Wang, Fulin, et al.
Publicado: (2021)

Timing of angiography and outcomes in patients with non-ST-segment elevation myocardial infarction: Insights from the evaluation and management of patients with acute chest pain in China registry
por: Han, Yu, et al.
Publicado: (2022)

Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Role of VEGFA gene polymorphisms in colorectal cancer patients who treated with bevacizumab
por: Cui, Wei, et al.
Publicado: (2017)

Development and Validation of a Simple-to-Use Nomogram for Predicting In-Hospital Mortality in Patients With Acute Heart Failure Undergoing Continuous Renal Replacement Therapy
por: Gao, Luyao, et al.
Publicado: (2021)

Status and Future Directions of Therapeutics and Prognosis of Cardiac Amyloidosis
por: Zhang, Wenbing, et al.
Publicado: (2023)

Inhibition of adenosine kinase attenuates myocardial ischaemia/reperfusion injury
por: Wang, Wenjun, et al.
Publicado: (2021)

Editorial: Integrated Motor-Cognitive Aerobic Rehabilitation Approaches in Parkinson's Disease
por: Canesi, Margherita, et al.
Publicado: (2021)

Macrophage Migration Inhibitory Factor (MIF) Deficiency Exacerbates Aging-Induced Cardiac Remodeling and Dysfunction Despite Improved Inflammation: Role of Autophagy Regulation
por: Xu, Xihui, et al.
Publicado: (2016)

Bevacizumab-Based Chemotherapy Combined with Regional Deep Capacitive Hyperthermia in Metastatic Cancer Patients: A Pilot Study
por: Ranieri, Girolamo, et al.
Publicado: (2017)

The efficacy and safety of irinotecan ± bevacizumab compared with oxaliplatin ± bevacizumab for metastatic colorectal cancer: A meta-analysis
por: Dai, Jiali, et al.
Publicado: (2019)

Polyvinylpyrrolidone as additive for perovskite solar cells with water and isopropanol as solvents
por: Du, Chen, et al.
Publicado: (2019)

Multi-GNSS Combined Orbit and Clock Solutions at iGMAS
por: Zhou, Wei, et al.
Publicado: (2022)

Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes: a meta-analysis
por: Qiao, Yanxiang, et al.
Publicado: (2013)

Deubiquitinase OTUD5 as a Novel Protector against 4‐HNE‐Triggered Ferroptosis in Myocardial Ischemia/Reperfusion Injury
por: Liu, Lulu, et al.
Publicado: (2023)

Increased Risk of Cerebrovascular Events in Patients with Cancer Treated with Bevacizumab: A Meta-Analysis
por: Zuo, Pei-Yuan, et al.
Publicado: (2014)

Clinical outcomes with bevacizumab-containing and non-bevacizumab–containing regimens in patients with recurrent glioblastoma from US community practices
por: Chen, Clara, et al.
Publicado: (2015)

Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery
por: Zuo, Lei, et al.
Publicado: (2018)

Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Wang, Jia-Kang, et al.
Publicado: (2016)

Biomarker-based risk model to predict cardiovascular events in patients with acute coronary syndromes – Results from BIPass registry
por: Wang, Jiali, et al.
Publicado: (2022)

Aldehyde Dehydrogenase 2 Protects Against Post-Cardiac Arrest Myocardial Dysfunction Through a Novel Mechanism of Suppressing Mitochondrial Reactive Oxygen Species Production
por: Zhang, Rui, et al.
Publicado: (2020)

Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: a retrospective study
por: Huang, Chunlong, et al.
Publicado: (2021)

Dual-Mode Biosensor for Simultaneous and Rapid Detection of Live and Whole Salmonella typhimurium Based on Bioluminescence and Fluorescence Detection
por: Xu, Zhenli, et al.
Publicado: (2023)

The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants
por: Guo, Mingyue, et al.
Publicado: (2022)

Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab
por: Wang, Dawei, et al.
Publicado: (2019)

Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports
por: Hsu, Ping-Chih, et al.
Publicado: (2023)

Mirabegron displays anticancer effects by globally browning adipose tissues
por: Sun, Xiaoting, et al.
Publicado: (2023)

Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
por: Xu, Wei, et al.
Publicado: (2016)

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
por: Wang, Feng, et al.
Publicado: (2022)

Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016)

The influence mechanism of nano-alumina content in semi-solid ceramic precursor fluid on the forming performance via a light-cured 3D printing method
por: Yang, Kepeng, et al.
Publicado: (2020)

Angiogenesis Inhibitor Bevacizumab Increases the Risk of Ischemic Heart Disease Associated with Chemotherapy: A Meta-Analysis
por: Chen, Xing-Lin, et al.
Publicado: (2013)

Osimertinib in combination with bevacizumab in EGFR-Mutated NSCLC with leptomeningeal metastases
por: Jiang, Tao, et al.
Publicado: (2020)

Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer
por: Xu, Ran, et al.
Publicado: (2018)

Bevacizumab for glioblastoma
por: Narita, Yoshitaka
Publicado: (2015)

Intravitreal bevacizumab
por: Khamar, Bakulesh M
Publicado: (2018)

Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy
por: Sápi, Johanna, et al.
Publicado: (2015)

Cost-effectiveness analysis of the addition of bevacizumab to temozolomide therapy for the treatment of unresected glioblastoma
por: Chen, Zhaoyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l9sfls4u1tbmpld3uemsput1hc